Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial program

Int J Antimicrob Agents. 2018 Jun;51(6):941-942. doi: 10.1016/j.ijantimicag.2018.02.008. Epub 2018 Feb 19.

¹ Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Queensland, Australia. Electronic address: [email protected].
² Department of Pharmacy, Royal Brisbane and Women's Hospital, Queensland, Australia; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
³ UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
⁴ Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Queensland, Australia.
⁵ Department of Pharmacy, Royal Brisbane and Women's Hospital, Queensland, Australia.
⁶ Infectious Diseases Unit, Royal Brisbane and Women's Hospital, Queensland, Australia; UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

No abstract available

Publication types